Tilray Brands' fiscal 2026 revenue rose 11% to a record $915.5 million, while adjusted EBITDA reached $61.1 million. Shares are down nearly 56% this year; The Motley Fool cites dilution and continued lack of GAAP profitability.
The fiscal year ended May 31. Tilray reported gross profit up 8% and adjusted EBITDA up 11.1%, from $55 million to $61.1 million. Recreational cannabis accounted for less than a third of sales; alcoholic beverages, medical cannabis distribution and wellness products made up the rest.
Management forecasts $1 billion in revenue for the current fiscal year and further adjusted EBITDA growth. The article cites $235 million in cash and a nearly debt-free balance sheet, but says Tilray has little exposure to the U.S. recreational cannabis market. Its share count rose from 116.5 million on Jan. 6 to 136.2 million on July 26. Tilray also has an upcoming agreement to license and sell Carlsberg-branded beer in the United States.
